Monsanto sales up 14% in fiscal 2012
Despite a dip in fourth-quarter revenues, Monsanto’s sales rose by 14.3% to $13,516 million in its fiscal year ended August 31st 2012. Seed and trait sales were up by 14.2% to $9,801 million and agrochemical revenues rose by 14.7% to $3,715 million. Gross profit increased by 15.9% to $7,045 million, with ongoing earnings per share (EPS) growth of 25%. “We’ve proven our business on a global stage, with back-to-back years of tremendous performance and momentum,” says Monsanto’s chairman and CEO, Hugh Grant.